Aviptadil is an injectable synthetic formulation of human vasoactive intestinal peptide (VIP).VIP was discovered in 1970, and has been used to treat various inflammatory conditions, such as acute respiratory distress syndrome (ARDS), asthma and chronic obstructive pulmonary disease (BPCO).
Aviptadil Acetate can diastolic blood vessels to lower blood pressure.It has a strong role in promoting secretion of intestinal fluid.But weak in the secretion of pancreatic.It can inhibit the secretion of gastric juice and gastrointestinal smooth muscle contraction.Aviptadil Acetate has a weak effect on blood sugar.
